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Purpose: Osteoarthritis (OA) of the foot and ankle is associated with pain and 
reduced function. Research has historically been focused on the hip and knee, and 
there is less evidence and understanding of treatment options for patients with OA 
of the foot or ankle. Therefore, the purpose was to systematically review available 
evidence for the efficacy of non-surgical and non-pharmacological treatment 
options in adult patients with osteoarthritis of the foot or ankle. 
Methods: Preferred Reporting Items for Systematic Reviews and Meta-Analysis 
(PRISMA) Statement guidelines were followed and the protocol was registered 
with the International Prospective Register of Systematic reviews (PROSPERO 
registration number CRD42018106390). A comprehensive search of MEDLINE, 
CINAHL, AMED, PubMed, PsycInfo, SPORTDiscus, Central Register of 
Controlled Trials, Web of Knowledge/Science and the Cochrane databases from 
their inception to 9thSeptember 2019 was conducted (Figure 1). Studies were 
screened using predefined inclusion/exclusion criteria. a) adult human participants 
with a clinical or radiological diagnosis of the ankle or foot, b) non-
pharmacological or non-surgical intervention and c) patient reported outcome 
measure for pain, function, quality of life or wellbeing. Studies were excluded if 
they evaluated rehabilitation in conjunction with surgical or pharmacological 
interventions. The studies were assessed for quality and risk of bias. Analysis was 
undertaken for the efficacy of the interventions described in the data. The search 
strategy was developed using the Population, Intervention, Comparison, Outcome 
and Study design (PICOS) framework and was adapted for each information 
source13. Restrictions were placed for adult, and human only studies. 
Methodological quality was assessed by the modified Downs and Black tool and 
study quality was based on previous literature: excellent (26-28); good (20-25); fair 
(15-19) and poor (≤14) (Figure 2). A manual reference list search of included 
studies did not reveal additional studies. 
Results: Of 408 identified studies, the abstracts of 271 unique studies were 
screened. 42 full text articles were assessed for eligibility. 9 satisfied the inclusion 
criteria for analysis in the review. These were 1 randomised trial, 1 randomised 
controlled trial (RCT) feasibility study, 1 quasi-randomised controlled trial, a pilot 
case-control study, 3 case series, 1 prospective comparative study and 1 
retrospective cross sectional study. There were a total of 378 recruited participants 
of whom 363 had an OA diagnosis and 15 were healthy individuals with no history 
of OA. Four studies looked at first metatarsophalangeal (MTP) joint OA, 4 studies 
looked at midfoot OA which included the first metarso-cuneiform joint, second 
metatarso-cuneiform joint, the navicular-cuneiform joint and the talo-navicular 
joint, and one study reported results for pedal OA defined as pain in the ankle, heel 
and forefoot location ‘all diagnosed radiographically as OA’. No studies reported 
data for left, right or bilateral feet symptoms separately, nor were results reported 
independently for male and female participants. The interventions assessed were 
custom made insoles, rocker sole footwear, shoe-stiffening inserts and carbon fibre 
footplates and physiotherapy interventions of joint mobilisations, manipulation, 
strengthening exercises, gait training, advice and education. In shoe orthotics or 
insoles had the largest number of studies and focused on midfoot and first 
metatarsophalangeal OA. Two studies focused on manual therapy and strength 
training for first metatarsophalangeal OA. No studies focused on treatments 
specifically for ankle OA. Meta-analyses for pain, function, quality of life or well-
being outcomes were not possible due to the heterogeneity of the results. 
Conclusions: There is tentative evidence that full length carbon fibre inserts are 
effective in the treatment of pain and improving physical function in subjects with 
midfoot OA. But, it is yet to be established if foot orthoses are a more effective 
treatment for this patient population than rocker-soled shoes. The use of orthoses 
in the treatment of foot pain and physical function for first MTP OA has minimal 
evidence and there is a small body of low-quality evidence for the use of specific 
manual therapy techniques, strengthening exercises and gait training in this same 
population. There is a paucity of evidence to sufficiently address this review’s 
objectives in terms of quality of life and wellbeing outcomes and there remains no 
evidence to investigate the efficacy of non-pharmacological and non-surgical 


























Records identified though Database Screening n=408
Web of Science n=157







identified through other 
sources n=0
Records after duplicates removed n=271
Records Screened n=271
Records excluded n=229:
Non Human Studies n=10
Non OA Pathologies n=119
Pharmacological Studies n=10
Assessment of OA n=37
Non Foot/Ankle OA n=21
Epidemiology studies n=14
Non Adult Studies n=3
Surgical studies n=1
Editorials or commentary n=8
Outcome Measure validation  
n=4
Health economics n=2
Full text articles assessed for eligibility n=42
Full text excluded n=34:
Non Human Studies n=1
Non OA Pathologies n=8
Pharmacological Studies n=1
Non Foot/Ankle OA n=5
Summary of treatment n=5
Healthy subjects n=1
Did not answer research 
question n=10
Protocol, results available in 
another paper n=1
Protocol only, results not 
available at time of review n=1
Editorial or commentary n=1
Studies included in qualitative analysis n=9
1 study identified from Cochrane systematic review so original 
trial included. 
Studies included in Meta-analysis n=0 High heterogeneity, n=9
 










































































































































1. Is the hypothesis/aim/objective of the study clearly described? 1 1 1 1 1 1 1 1 1 100 
2. Are the main outcomes to be measured clearly described in the 
Introduction or Methods section? 
1 1 1 1 1 1 1 1 1 100 
3. Are the characteristics of the patients included in the study 
clearly described? 
0 1 1 1 1 1 1 1 1 89 
4. Are the interventions of interest clearly described? 1 1 1 1 1 1 1 0 1 89 
5. Are the distributions of principal confounders in each group of 
subjects to be compared clearly described? 
0 2 0 2 2 0 0 1 2 44 
6. Are the main findings of the study clearly described? 1 1 1 1 1 1 1 0 1 89 
7. Does the study provide estimates of the random variability in the 
data for the main outcomes? 
0 1 1 1 1 1 1 0 1 78 
8. Have all important adverse events that may be a consequence 
of the intervention been reported? 
1 1 0 1 1 0 0 0 0 44 
9. Have the characteristics of patients lost to follow‐up been 
described? 
1 1 1 1 1 1 1 1 1 100 
10. Have actual probability values been reported (e.g. 0.035 rather 
than <0.05) for the main outcomes except where the probability 
value is less than 0.001? 
0 0 0 1 1 1 0 0 1 44 
External Validity 
11. Were the subjects asked to participate in the study 
representative of the entire population from which they were 
recruited? 
0 0 0 0 0 0 0 0 0 0 
12. Were those subjects who were prepared to participate 
representative of the entire population from which they were 
recruited? 
0 0 0 1 0 0 0 0 0 11 






































































































































13. Were the staff, places, and facilities where the patients were 
treated, representative of the treatment the majority of patients 
receive? 
0 1 0 0 0 0 0 1 1 33 
Internal Validity – Bias 
14. Was an attempt made to blind study subjects to the 
intervention they have received? 
0 1 0 0 0 0 0 0 0 11 
15. Was an attempt made to blind those measuring the main 
outcomes of the intervention? 
0 1 0 0 1 0 0 0 0 22 
16. If any of the results of the study were based on “data 
dredging”, was this made clear? 
1 1 1 1 1 1 1 1 1 100 
17. In trials and cohort studies, do the analyses adjust for different 
lengths of follow‐up of patients, or in case‐control studies, is the 
time period between the intervention and outcome the same for 
cases and controls? 
1 1 1 1 1 1 1 0 1 89 
18. Were the statistical tests used to assess the main outcomes 
appropriate? 
1 1 1 1 1 1 1 0 1 89 
19. Was compliance with the intervention/s reliable? 1 1 0 0 1 0 1 1 1 67 
20. Were the main outcome measures used accurate (valid and 
reliable)? 
1 1 0 1 1 1 1 0 1 78 
Internal Validity – Confounding 
21. Were the patients in different intervention groups (trials and 
cohort studies) or were the cases and controls (case‐control 
studies) recruited from the same population? 
0 1 1 0 1 1 1 1 0 67 
22. Were study subjects in different intervention groups (trials and 
cohort studies) or were the cases and controls (case‐control 
studies) recruited over the same period of time? 
0 0 0 0 1 0 0 0 0 11 
23. Were study subjects randomised to intervention groups? 0 1 0 0 1 0 0 0 0 22 
24. Was the randomised intervention assignment concealed from 
both patients and health care staff until recruitment as complete 
and irrevocable? 
0 1 0 0 0 0 0 0 0 11 
25. Was there adequate adjustment for confounding in the 
analyses from which the main findings were drawn? 
0 0 0 1 0 0 0 0 1 22 
26. Were losses of patients to follow‐up taken into account? 1 1 1 1 1 1 1 1 1 100 
Power – Modified17,18,19 
27. Did the study have sufficient power to detect a clinically 
important effect where the probability value for a difference being 
due to chance is less than 5%? 
Sample sizes have been calculated to detect a difference of x% 
and y%. 
0 0 1 0 1 0 1 0 0 33 
Total score: /28 12 22 13 18 22 14 15 10 18  
Green Shading = Full Score, Amber shading = Partial Score, Red shading = No score or unable 
to determine 
 
Figure 2. Results from quality Assessment of all included papers 
